Diarrhea

A U.S. District Court judge in Delaware has denied Norwich Pharmaceuticals’ motion to modify the court’s final judgment, which blocks the FDA from approving their 550 mg rifaximin generic until Oct. 2, 2029.

Travel is a common part of life that we often take for granted — from simple acts of running errands and commuting to work to the bigger trips of visiting out-of-state loved ones and experiencing life-changing moments of world travel.

Despite affecting nearly 10% of the population, irritable bowel syndrome remains highly stigmatized. During IBS Awareness Month, a gastrointestinal disease advocacy group has launched the #YouandIBS campaign to confront this stigma head on.

Colesevelam was superior to placebo in inducing remission in patients with bile acid diarrhea with no serious adverse events reported, according to results published in The Lancet Gastroenterology & Hepatology.

Specific and nonspecific acupoint acupuncture improved symptoms of diarrhea among a small subset of patients with irritable bowel syndrome, according to results from a pilot study reported in JAMA Network Open.

CHARLOTTE, N.C. — Daily treatment with Xifaxan over 2 weeks improved stool consistency and fecal urgency in adults with irritable bowel syndrome-diarrhea, according to a poster at the ACG Annual Scientific Meeting.

CHARLOTTE, N.C. — Treatment for irritable bowel syndrome with diarrhea should target bloating in addition to diarrhea and abdominal pain or discomfort, according to data presented at the ACG Annual Scientific Meeting.

PHILADELPHIA — Immunosuppressive or anti-fibrotic drugs do not appear to have any clear impact on worsening gastrointestinal symptoms in patients with early systemic sclerosis, according to data presented at ACR Convergence 2022.

In this edition, splash pads reduce child drowning risk but boost diarrhea outbreaks; FDA approves Konvomep for benign gastric ulcers; Xifaxan generic may be stalled until 2029 and more.

Use of an algorithm-based tool to determine the likelihood of viral etiology for acute diarrhea in children did not significantly reduce antibiotic prescriptions in developing countries, according to a study in JAMA Pediatrics.